These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9323834)

  • 1. Comments on the medium-term rat liver focus bioassay.
    Maronpot RR
    Toxicol Pathol; 1997; 25(5):461. PubMed ID: 9323834
    [No Abstract]   [Full Text] [Related]  

  • 2. A medium-term rat liver bioassay as a rapid in vivo test for carcinogenic potential: a historical review of model development and summary of results from 291 tests.
    Shirai T
    Toxicol Pathol; 1997; 25(5):453-60. PubMed ID: 9323833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medium-term rat liver bioassay for rapid detection of carcinogens and modifiers of hepatocarcinogenesis.
    Ito N; Hasegawa R; Imaida K; Takahashi S; Shirai T
    Drug Metab Rev; 1994; 26(1-2):431-42. PubMed ID: 8082578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medium-term carcinogenicity bioassay.
    Della Porta G
    Jpn J Cancer Res; 1992 Aug; 83(8):inside front cover. PubMed ID: 1399815
    [No Abstract]   [Full Text] [Related]  

  • 5. The inhalation exposure of carbon tetrachloride promote rat liver carcinogenesis in a medium-term liver bioassay.
    Tsujimura K; Ichinose F; Hara T; Yamasaki K; Otsuka M; Fukushima S
    Toxicol Lett; 2008 Feb; 176(3):207-14. PubMed ID: 18221844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medium-term liver and multi-organ carcinogenesis bioassays for carcinogens and chemopreventive agents.
    Ito N; Hasegawa R; Imaida K; Hirose M; Shirai T
    Exp Toxicol Pathol; 1996 Feb; 48(2-3):113-9. PubMed ID: 8672864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement and validation of a medium-term gpt delta rat model for predicting chemical carcinogenicity and underlying mode of action.
    Matsushita K; Kuroda K; Ishii Y; Takasu S; Kijima A; Kawaguchi H; Miyoshi N; Nohmi T; Ogawa K; Nishikawa A; Umemura T
    Exp Toxicol Pathol; 2014 Sep; 66(7):313-21. PubMed ID: 24929978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of GST-P positive liver cell foci development by a medium-term carcinogenicity bioassay using repeated administration of D-galactosamine.
    Kim HC; Lee YS; Furukawa F; Nishikawa A; Takahashi M
    Cancer Lett; 1995 Nov; 98(1):71-6. PubMed ID: 8529208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medium-term bioassays in rats for rapid detection of the carcinogenic potential of chemicals.
    Shirai T; Hirose M; Ito N
    IARC Sci Publ; 1999; (146):251-72. PubMed ID: 10353390
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhancing effects of Thai edible plants on 2-amino-3, 8-dimethylimidazo(4,5-f)quinoxaline-hepatocarcinogenesis in a rat medium-term bioassay.
    Tiwawech D; Hirose M; Futakuchi M; Lin C; Thamavit W; Ito N; Shirai T
    Cancer Lett; 2000 Oct; 158(2):195-201. PubMed ID: 10960770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogenesis risk assessment of chemicals using medium-term carcinogenesis bioassays.
    Tamano S
    Asian Pac J Cancer Prev; 2010; 11(1):4-5. PubMed ID: 20593916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of carcinogenicity of daminozide, alone or in combination with its contaminant 1,1-dimethylhydrazine, in a medium-term bioassay.
    Cabral R; Hakoi K; Hoshiya T; Hasegawa R; Ito N
    Teratog Carcinog Mutagen; 1995-1996; 15(6):307-12. PubMed ID: 8732881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary on "Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary".
    Long GG
    Toxicol Pathol; 2010 Apr; 38(3):502-5. PubMed ID: 20124495
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancing effects of phenobarbital and 3-methylcholanthrene on GST-P-positive liver cell foci development in a new medium-term rat liver bioassay using D-galactosamine.
    Kim HC; Lee YS; Nishikawa A
    J Toxicol Environ Health; 1997 Apr; 50(5):519-28. PubMed ID: 9140468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and emerging challenges in toxicopathology: carcinogenic threshold of phenobarbital and proof of arsenic carcinogenicity using rat medium-term bioassays for carcinogens.
    Fukushima S; Morimura K; Wanibuchi H; Kinoshita A; Salim EI
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):225-9. PubMed ID: 15993454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of GST-P positive preneoplastic hepatic foci in dose-response studies of hepatocarcinogenesis: evidence for practical thresholds with both genotoxic and nongenotoxic carcinogens. A review of recent work.
    Tsuda H; Fukushima S; Wanibuchi H; Morimura K; Nakae D; Imaida K; Tatematsu M; Hirose M; Wakabayashi K; Moore MA
    Toxicol Pathol; 2003; 31(1):80-6. PubMed ID: 12597451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of carbamate insecticides in a rat medium-term bioassay for hepatocarcinogens.
    Tanaka H; Hasegawa R; Takesada Y; Ogiso T; Hirose M; Shirai T
    J Toxicol Environ Health; 1996 Apr; 47(5):493-8. PubMed ID: 8614018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternatives to the carcinogenicity bioassay for toxicity prediction: are we there yet?
    Benigni R
    Expert Opin Drug Metab Toxicol; 2012 Apr; 8(4):407-17. PubMed ID: 22360376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An enhanced 13-week bioassay: an alternative to the 2-year bioassay to screen for human carcinogenesis.
    Cohen SM
    Exp Toxicol Pathol; 2010 Sep; 62(5):497-502. PubMed ID: 19616417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concordance of thresholds for carcinogenicity of N-nitrosodiethylamine.
    Waddell WJ; Fukushima S; Williams GM
    Arch Toxicol; 2006 Jun; 80(6):305-9. PubMed ID: 16308687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.